Luo F - Search Results

1

[Expression of PIM-1 in prostate cancer tissue and its relationship with PSA recurrence].

Zhang CT, Xu Y, Luo F, Zhang ZH, Liu RL, Yang K, Ma BJ. Zhang CT, et al. Among authors: luo f. Zhonghua Nan Ke Xue. 2012 Apr;18(4):323-6. Zhonghua Nan Ke Xue. 2012. PMID: 22574367 Chinese.

2

Formation of vasculogenic mimicry in bone metastasis of prostate cancer: correlation with cell apoptosis and senescence regulation pathways.

Luo F, Yang K, Liu RL, Meng C, Dang RF, Xu Y. Luo F, et al. Pathol Res Pract. 2014 May;210(5):291-5. doi: 10.1016/j.prp.2014.01.005. Epub 2014 Feb 5. Pathol Res Pract. 2014. PMID: 24581724

3

Iodine-125 seed implantation and deferred transurethral resection of the prostate for patients with lower urinary tract symptoms and localized prostate cancer.

Liu R, Luo F, Zhang Z, Xu Y. Liu R, et al. Among authors: luo f. Clin Genitourin Cancer. 2013 Sep;11(3):251-5. doi: 10.1016/j.clgc.2012.12.010. Epub 2013 Jan 29. Clin Genitourin Cancer. 2013. PMID: 23375828

4

Clinical significance of NUCB2 mRNA expression in prostate cancer.

Zhang H, Qi C, Li L, Luo F, Xu Y. Zhang H, et al. Among authors: luo f. J Exp Clin Cancer Res. 2013 Aug 16;32(1):56. doi: 10.1186/1756-9966-32-56. J Exp Clin Cancer Res. 2013. PMID: 23958433 Free PMC article.

5

Bone marrow mesenchymal stem cells participate in prostate carcinogenesis and promote growth of prostate cancer by cell fusion in vivo.

Luo F, Liu T, Wang J, Li J, Ma P, Ding H, Feng G, Lin D, Xu Y, Yang K. Luo F, et al. Oncotarget. 2016 May 24;7(21):30924-34. doi: 10.18632/oncotarget.9045. Oncotarget. 2016. PMID: 27129157 Free PMC article.

6

Exonuclease 1 expression is associated with clinical progression, metastasis, and survival prognosis of prostate cancer.

Luo F, Wang YZ, Lin D, Li J, Yang K. Luo F, et al. J Cell Biochem. 2019 Jul;120(7):11383-11389. doi: 10.1002/jcb.28415. Epub 2019 Feb 18. J Cell Biochem. 2019. PMID: 30775798

7

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density.

Chen Y, Jiang X, Liu R, Zhang Z, Luo F, Qi S, Xu Y. Chen Y, et al. Among authors: luo f. Med Sci Monit. 2019 Aug 19;25:6230-6235. doi: 10.12659/MSM.915826. Med Sci Monit. 2019. PMID: 31424055 Free PMC article.

8

Lamin B1 promotes tumor progression and metastasis in primary prostate cancer patients.

Luo F, Han J, Chen Y, Yang K, Zhang Z, Li J. Luo F, et al. Future Oncol. 2021 Feb;17(6):663-673. doi: 10.2217/fon-2020-0825. Epub 2020 Oct 28. Future Oncol. 2021. PMID: 33112662

9

Screening key miRNAs and genes in prostate cancer by microarray analysis.

Wu J, Li X, Luo F, Yan J, Yang K. Wu J, et al. Among authors: luo f. Transl Cancer Res. 2020 Feb;9(2):856-868. doi: 10.21037/tcr.2019.12.30. Transl Cancer Res. 2020. PMID: 35117431 Free PMC article.

10

The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats.

Wang C, Luo F, Zhou Y, Du X, Shi J, Zhao X, Xu Y, Zhu Y, Hong W, Zhang J. Wang C, et al. Among authors: luo f. Exp Cell Res. 2016 Jul 15;345(2):125-33. doi: 10.1016/j.yexcr.2015.03.026. Epub 2015 Apr 4. Exp Cell Res. 2016. PMID: 25849092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,588 results

Search Page

Filters